arrow
J

Juliana Gurgel-Giannetti

Universidade Federal de Minas Gerais
H指数:20
被引数:1,616

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and tolerability of onasemnogene abeparvovec for patients with spinal muscular atrophy weighing ≤17 kg and ≤24 months old from OFELIA, a phase 4, open-label, multicenter, non-randomised, interventional study

来自OFELIA(一项第4期、开放标签、多中心、非随机化、干预性研究)的数据显示,onasemnogene abeparvovec在体重≤17 kg且年龄≤24个月的脊髓性肌萎缩症患儿中的安全性与耐受性。

2025-07-280
PRE
Thrombotic microangiopathy following gene therapy for 5q-spinal muscular atrophy

基因疗法治疗5q-脊髓性肌萎缩症后的血栓性微血管病

2025-06-190
PRE
Clinical and molecular spectrum of TK2-deficiency: a large Brazilian cohort

TK2-deficiency的临床和分子谱: 一个大型巴西队列

2025-03-150
OAAI
Spinal muscular atrophy in Latin American: Patient journey observed in regional registry
2023-12-010
PRE
Spinal muscular atrophy in Latin American: The registrame clinical registry
2023-12-010
PRE
Characterization of the profile of patients with spinal muscular atrophy types 2 and 3 being followed up in the Brazilian public health system
2023-12-010
PRE
DEVOTE Study Exploring Higher Dose of Nusinersen in Spinal Muscular Atrophy: Study Design and Part A Results

致力于探索高剂量Nusinersen治疗脊髓性肌萎缩症的研究: 研究设计和A部分结果

2023-01-017
PRE
Variants in CLDN5 cause a syndrome characterized by seizures, microcephaly and brain calcifications

CLDN5的变异引起以癫痫、小头畸形和脑钙化为特征的综合征

BRAIN
IF11.7
2022-12-089
OA
Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study

咖啡因对ADCY5-Related运动障碍的疗效: 一项回顾性研究

2022-04-0518
PRE
International retrospective natural history study of LMNA-related congenital muscular dystrophy
2021-04-1120
OAAI
Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophy
2020-10-0535
OAAI
A novel complex neurological phenotype due to a homozygous mutation in FDX2
BRAIN
IF11.7
2018-07-1332
OAAI